Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1992 2
1993 2
1994 3
1995 1
1996 1
1997 7
1998 2
1999 4
2000 11
2001 13
2002 16
2003 26
2004 42
2005 46
2006 44
2007 41
2008 49
2009 58
2010 65
2011 78
2012 87
2013 115
2014 120
2015 128
2016 167
2017 205
2018 235
2019 224
2020 328
2021 415
2022 404
2023 419
2024 406
2025 424
2026 78

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,826 results

Results by year

Filters applied: . Clear all
Page 1
Early palliative care for patients with metastatic non-small-cell lung cancer.
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Temel JS, et al. N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678. N Engl J Med. 2010. PMID: 20818875 Free article. Clinical Trial.
BACKGROUND: Patients with metastatic non-small-cell lung cancer have a substantial symptom burden and may receive aggressive care at the end of life. ...METHODS: We randomly assigned patients with newly diagnosed metastatic non-small-cell lung cance …
BACKGROUND: Patients with metastatic non-small-cell lung cancer have a substantial symptom burden and may receive aggressive …
Non-small cell lung cancer in China.
Chen P, Liu Y, Wen Y, Zhou C. Chen P, et al. Cancer Commun (Lond). 2022 Oct;42(10):937-970. doi: 10.1002/cac2.12359. Epub 2022 Sep 8. Cancer Commun (Lond). 2022. PMID: 36075878 Free PMC article. Review.
In China, lung cancer is a primary cancer type with high incidence and mortality. Risk factors for lung cancer include tobacco use, family history, radiation exposure, and the presence of chronic lung diseases. Most early-stage non-small …
In China, lung cancer is a primary cancer type with high incidence and mortality. Risk factors for lung cance …
Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options.
Zugazagoitia J, Paz-Ares L. Zugazagoitia J, et al. J Clin Oncol. 2022 Feb 20;40(6):671-680. doi: 10.1200/JCO.21.01881. Epub 2022 Jan 5. J Clin Oncol. 2022. PMID: 34985925 Review.
Extensive-stage small-cell lung cancer is a therapeutically challenging disease. After more than two decades without clinical progress, the addition of programmed cell death protein 1 axis blockade to platinum-based chemotherapy has demonstrated sustained overall su …
Extensive-stage small-cell lung cancer is a therapeutically challenging disease. After more than two decades without clinical …
Preoperative and Postoperative Systemic Therapy for Operable Non-Small-Cell Lung Cancer.
Chaft JE, Shyr Y, Sepesi B, Forde PM. Chaft JE, et al. J Clin Oncol. 2022 Feb 20;40(6):546-555. doi: 10.1200/JCO.21.01589. Epub 2022 Jan 5. J Clin Oncol. 2022. PMID: 34985966 Free PMC article. Review.
Cisplatin-based adjuvant chemotherapy remains the standard of care for patients with resected stage II or III non-small-cell lung cancer. However, biomarker-informed clinical trials are starting to push the management of early-stage lung canc …
Cisplatin-based adjuvant chemotherapy remains the standard of care for patients with resected stage II or III non-small-cell …
Lung Cancer Treatment Advances in 2022.
Abu Rous F, Singhi EK, Sridhar A, Faisal MS, Desai A. Abu Rous F, et al. Cancer Invest. 2023 Jan;41(1):12-24. doi: 10.1080/07357907.2022.2119479. Epub 2022 Dec 12. Cancer Invest. 2023. PMID: 36036470
The therapeutic landscape of lung cancer treatment is changing rapidly, and new data was presented at the recently concluded American Society of Clinical Oncology 2022 (ASCO22) meeting. We highlight studies of clinical relevance that represent significant updates in …
The therapeutic landscape of lung cancer treatment is changing rapidly, and new data was presented at the recently concluded A …
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification.
Caliman E, Fancelli S, Petroni G, Gatta Michelet MR, Cosso F, Ottanelli C, Mazzoni F, Voltolini L, Pillozzi S, Antonuzzo L. Caliman E, et al. Lung Cancer. 2023 Jan;175:88-100. doi: 10.1016/j.lungcan.2022.11.014. Epub 2022 Nov 23. Lung Cancer. 2023. PMID: 36493578 Free article. Review.
For many years the standard of care for small cell lung cancer (SCLC) has remained unchanged. Despite decades of active research, current treatment options are limited and the prognosis of patients with extended disease (ED) SCLC remains poor. ...
For many years the standard of care for small cell lung cancer (SCLC) has remained unchanged. Despite decades of …
The current and emerging immunotherapy paradigm in small-cell lung cancer.
Qin K, Gay CM, Byers LA, Zhang J. Qin K, et al. Nat Cancer. 2025 Jun;6(6):954-966. doi: 10.1038/s43018-025-00992-5. Epub 2025 Jun 5. Nat Cancer. 2025. PMID: 40473974 Review.
Small-cell lung cancer (SCLC) is a highly aggressive malignancy with poor prognosis. For decades, etoposide-platinum-based chemotherapy had been the mainstay treatment for SCLC; however, despite initial high response rates, most patients developed resistance. In 201 …
Small-cell lung cancer (SCLC) is a highly aggressive malignancy with poor prognosis. For decades, etoposide-platinum-based che …
Impact research of pain nursing combined with hospice care on quality of life for patients with advanced lung cancer.
Yuan T, Zhou Y, Wang T, Li Y, Wang Y. Yuan T, et al. Medicine (Baltimore). 2024 May 31;103(22):e37687. doi: 10.1097/MD.0000000000037687. Medicine (Baltimore). 2024. PMID: 39259100 Free PMC article. Clinical Trial.
This study aims to evaluate the impact of integrating pain nursing with hospice care on the quality of life among patients with advanced lung cancer. This study involving 60 advanced lung cancer patients admitted from January 2022 to January 202 …
This study aims to evaluate the impact of integrating pain nursing with hospice care on the quality of life among patients with advan …
Advances in systemic therapy for non-small cell lung cancer.
Miller M, Hanna N. Miller M, et al. BMJ. 2021 Nov 9;375:n2363. doi: 10.1136/bmj.n2363. BMJ. 2021. PMID: 34753715 Review.
Lung cancer remains a leading cause of cancer related mortality worldwide. Despite numerous advances in treatments over the past decade, non-small cell lung cancer (NSCLC) remains an incurable disease for most patients. ...For patients with unre …
Lung cancer remains a leading cause of cancer related mortality worldwide. Despite numerous advances in treatments over …
Lung Cancer Screening.
Choi HK, Mazzone PJ. Choi HK, et al. Surg Oncol Clin N Am. 2020 Oct;29(4):509-524. doi: 10.1016/j.soc.2020.06.004. Epub 2020 Jul 20. Surg Oncol Clin N Am. 2020. PMID: 32883455 Review.
Lung cancer is the leading cause of US cancer-related deaths. Lung cancer screening with a low radiation dose chest computed tomography scan is now standard of care for a high-risk eligible population. It is imperative for clinicia …
Lung cancer is the leading cause of US cancer-related deaths. Lung cancer screening with a low radiation …
3,826 results